Positive Surgical Margins in the 10 Most Common Solid Cancers

[1]  F. Q. Ribeiro.  The meta-analysis , 2017, Brazilian journal of otorhinolaryngology.

[2]  R. Osarogiagbon,et al.  Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria. , 2017, The Annals of thoracic surgery.

[3]  S. Hendren,et al.  Colorectal cancer: Quality of surgical care in Michigan. , 2017, American journal of surgery.

[4]  J. Jenkins,et al.  Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival , 2017, Diseases of the colon and rectum.

[5]  R. Jagsi,et al.  Cost and Complications of Local Therapies for Early-Stage Breast Cancer , 2017, Journal of the National Cancer Institute.

[6]  W. Nieves-Neira,et al.  Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study. , 2016, Gynecologic oncology.

[7]  Q. Chu,et al.  Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer. , 2016, Surgery.

[8]  Steven L. Chang,et al.  Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Charles S. Coffey,et al.  Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Singhal,et al.  Clinical implications of positive margins following non‐small cell lung cancer surgery , 2016, Journal of surgical oncology.

[11]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[12]  J. Shah,et al.  Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  R. Osarogiagbon,et al.  Improving lung cancer outcomes by improving the quality of surgical care. , 2015, Translational lung cancer research.

[14]  A. Paravati,et al.  Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer. , 2015, Journal of oncology practice.

[15]  G. Giaccone,et al.  Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States , 2015, Front. Oncol..

[16]  J. Eastham,et al.  The association between nerve sparing and a positive surgical margin during radical prostatectomy. , 2015, Urologic oncology.

[17]  M. Usel,et al.  Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study , 2014, BMC Urology.

[18]  J. McKiernan,et al.  Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer. , 2014, Urologic oncology.

[19]  J. Eastham,et al.  Significance and management of positive surgical margins at the time of radical prostatectomy , 2014, Indian journal of urology : IJU : journal of the Urological Society of India.

[20]  S. Roman,et al.  Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival: An Analysis of 61,775 Patients , 2014, Annals of surgery.

[21]  Zhen Cheng,et al.  Fluorescent imaging of cancerous tissues for targeted surgery. , 2014, Advanced drug delivery reviews.

[22]  S. Roman,et al.  Positive Surgical Margins in Early Stage Oral Cavity Cancer , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[23]  E. Baudin,et al.  Resection margins and prognosis in locally invasive thyroid cancer , 2014, Head & neck.

[24]  Seema A Khan,et al.  Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer , 2014, Annals of Surgical Oncology.

[25]  Fumihiro Tanaka,et al.  Recurrence after surgery in patients with NSCLC. , 2014, Translational lung cancer research.

[26]  S. Hohmann,et al.  Costs of Outpatient Thyroid Surgery from the University HealthSystem Consortium (UHC) Database , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[27]  Markus Graefen,et al.  Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. , 2014, European urology.

[28]  Yin Zhang,et al.  Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. , 2014, Current pharmaceutical biotechnology.

[29]  Shung-Haur Yang,et al.  Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision. , 2013, American journal of surgery.

[30]  Jihad H Kaouk,et al.  Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind). , 2013, The Journal of urology.

[31]  L. Lacombe,et al.  The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients. , 2013, European urology.

[32]  P. Dasgupta,et al.  1031 Intra-corporeal versus extra-corporeal urinary diversion after robot-assisted radical cystectomy: Results from the International Robotic Cystectomy Consortium , 2013 .

[33]  Marco Borghesi,et al.  Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. , 2013, Clinical genitourinary cancer.

[34]  Markus Graefen,et al.  Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. , 2012, European urology.

[35]  T. Skolarus,et al.  Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. , 2012, Health affairs.

[36]  Klaus Jeschke,et al.  Positive surgical margins after nephron-sparing surgery. , 2012, European urology.

[37]  J. Saldivar.  Cancer of the Uterine Endometrium - Advances and Controversies , 2012 .

[38]  F. Odicino,et al.  Controversies in the Surgery of Endometrial Cancer , 2012 .

[39]  C. Hong,et al.  Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation , 2012, Annals of Nuclear Medicine.

[40]  H. Feigelson,et al.  Variability in reexcision following breast conservation surgery. , 2012, JAMA.

[41]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[42]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[43]  M. Morrow,et al.  Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  K. Markou,et al.  National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .

[45]  J. McKiernan,et al.  Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys , 2011, World Journal of Urology.

[46]  Electron Kebebew,et al.  Thyroid cancer gender disparity. , 2010, Future oncology.

[47]  R. T. Divrik,et al.  Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. , 2010, European urology.

[48]  E. Mazzaferri,et al.  Thyroid cancer epidemiology and prognostic variables. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[49]  J. Kaouk,et al.  Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. , 2010, The Journal of urology.

[50]  W. Ellis,et al.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. , 2010, The Journal of urology.

[51]  A. Cazes,et al.  Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis. , 2010, The Annals of thoracic surgery.

[52]  Sam S. Chang,et al.  Margin control in open radical prostatectomy: what are the real outcomes? , 2010, Urologic oncology.

[53]  A. Zisman,et al.  Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. , 2010, Urology.

[54]  J. Schorge,et al.  Surgical debulking of ovarian cancer: what difference does it make? , 2010, Reviews in obstetrics & gynecology.

[55]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[56]  J. Griggs,et al.  Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. , 2009, JAMA.

[57]  N. Wada,et al.  Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. , 2009, Lung cancer.

[58]  S. Rubin,et al.  Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  A. Jazaeri,et al.  A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. , 2008, Gynecologic oncology.

[60]  K. Kavanagh,et al.  Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. , 2007, The Journal of urology.

[61]  H. Putter,et al.  The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma , 2007, Annals of surgery.

[62]  R. Nason,et al.  The clinical significance of the positive surgical margin in oral cancer. , 2007, Oral oncology.

[63]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[64]  J. Wind,et al.  Residual disease at the bronchial stump after curative resection for lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[65]  H. Dienemann,et al.  Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. , 2007, Lung cancer.

[66]  D. Levine,et al.  What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? , 2007, Gynecologic oncology.

[67]  P. Maisonneuve,et al.  Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[68]  Andrew K Stewart,et al.  Patterns of surgical care of lung cancer patients. , 2005, The Annals of thoracic surgery.

[69]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[70]  Bengt Bergman,et al.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.

[71]  Merrick I Ross,et al.  Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy , 2003, Cancer.

[72]  S. Rogers,et al.  The prognostic implications of the surgical margin in oral squamous cell carcinoma. , 2003, International journal of oral and maxillofacial surgery.

[73]  A. Gadducci,et al.  Treatment planning in endometrial cancer , 2003 .

[74]  R. Evans.  Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy , 2003, Cancer.

[75]  E. Trimble,et al.  Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  E. Sartori,et al.  Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapy , 2001, International Journal of Gynecologic Cancer.

[77]  J. Shah,et al.  Differentiated carcinoma of the thyroid with extrathyroidal extension. , 1995, American journal of surgery.

[78]  J. Berek,et al.  The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. , 1994, American journal of obstetrics and gynecology.

[79]  A. Jones.  Prognosis in mouth cancer: tumour factors. , 1994, European journal of cancer. Part B, Oral oncology.

[80]  E. Strong,et al.  Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. , 1993, American journal of surgery.

[81]  J. Jacobs,et al.  Implications of positive surgical margins , 1993, The Laryngoscope.

[82]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[83]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[84]  L J Emrich,et al.  The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. , 1987, International journal of radiation oncology, biology, physics.